comparemela.com

Latest Breaking News On - Michaelm morrissey - Page 1 : comparemela.com

Exelixis Announces Fourth Quarter and Fiscal Year 2023 Financial Results and Provides Corporate Upda

- Total Revenues of $480 million for the Fourth Quarter of 2023, $1,830 million for the Fiscal Year 2023 Cabozantinib Franchise Achieved $1,629 million in U.S. Net Product Revenues for the Fiscal Year 2023, including $429 million for the Fourth Quarter of 2023 GAAP Diluted EPS of $0.27 for the Fourth Quarter o.

Exelixis Announces Fourth Quarter and Fiscal Year 2023 Financial Results and Provides Corporate Update

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.